Brief: Elicera Therapeutics Q2 Operating Loss Widens To SEK 3.7 Million

Elicera Therapeutics AB

22/08/2022 07:18

Aug 22 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * Q2 LOSS FOR PERIOD TOTALED SEK -3,667,200 (-1,818,888)
    * Q2 OPERATING LOSS TOTALED SEK -3,641,800 (-1,818,751)
    * WE BELIEVE THAT WITH OUR EXISTING CASH AND BANK BALANCES,
EU
GRANT AND OTHER GRANTS, WE HAVE FINANCING TO CARRY OUT ALL OUR
PROGRAMS AT FULL SPEED UNTIL FIRST HALF OF 2024

Source text for Eikon:  ID:nWkr8Xml4B 
Further company coverage:  ELIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))